Medication info
Megaciproflox Tablet (Ciprofloxacin Hydrochloride Hydrate)

Megaciproflox Tablet (Ciprofloxacin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201901582 · Approved 2019.03.15 · Insurance code 060500050

Summary

Main use
Treatment of bacterial infections (urinary tract, respiratory tract, skin, etc.)
Who takes it
Adults
Adult dose
○ Adults: The usual dose of ciprofloxacin is 250 ~ 500 mg orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. Acute infections are usually treated for 5 ~ 10 days, and treatment should continue for at least 3 days after symptoms have disappeared. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/min: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients on hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formulas: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, monitor the patient's condition closely after administration. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Treatment of bacterial infections (urinary tract, respiratory tract, skin, etc.)

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute uncomplicated cystitis
  • acute pyelonephritis
View approved original text

This medication is used to treat various infections caused by several bacteria. For instance, it is effective against respiratory infections such as community-acquired pneumonia, and upper respiratory tract infections such as pharyngitis, tonsillitis, laryngitis, otitis externa, chronic cholesteatomatous otitis media, and chronic otitis media. It is also used for the treatment of bacterial prostatitis, acute uncomplicated cystitis, and acute pyelonephritis among urinary tract infections. Additionally, it is effective for gastrointestinal infections, biliary infections, skin and soft tissue infections, and bone and joint infections. It also treats gynecological infections, peritonitis, nabothian cysts, and chalazia. However, in some diseases, its use is recommended only when no other treatment options are available. This medicine helps improve various bacterial infections.

How to take

Adult dose

○ Adults: The usual dose of ciprofloxacin is 250 ~ 500 mg orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. Acute infections are usually treated for 5 ~ 10 days, and treatment should continue for at least 3 days after symptoms have disappeared. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/min: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients on hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formulas: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, monitor the patient's condition closely after administration. Adjust the dose as appropriate according to symptoms.

Precautions

This medication belongs to a specific class of antibiotics and can cause severe side effects such as tendonitis or tendon rupture. Particularly, patients with severe myasthenia gravis should not use it due to the risk of exacerbation of symptoms. This medication is only used restrictively for certain infections and is recommended to be administered only when no other treatment options are available. Elderly patients, those with impaired kidney function, and those taking certain medications should exercise caution when using this medicine. Additionally, it is not administered to pregnant or lactating women or to children under the age of 18. If pain or inflammation occurs in the tendons while taking this medication, discontinue use immediately and consult a physician. There may also be side effects such as seizures, dizziness, and mental abnormal symptoms, which should be reported immediately if they occur. This medication can interact with several medications, so it is essential to inform healthcare providers of any other medications being taken. Particularly, caution is needed when used with specific sedatives, anticonvulsants, or hypoglycemic agents. During treatment, care should be taken to avoid strong sunlight or ultraviolet light exposure, and if any skin adverse reactions such as rashes or itching occur, use should be discontinued immediately. Overdosing may cause kidney damage, so it is vital to adhere to the prescribed dosage and keep the medication out of reach of children during storage.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, decreased red blood cells, decreased hemoglobin, decreased hematocrit, decreased granulocytes, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic swelling, vascular edema, anaphylactic reactions, anaphylactoid shock, serum sickness-like reaction, loss of appetite, decreased food intake, increased blood alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory abnormalities, sensory loss, loss of taste, tremor, spasm, vertigo, mental confusion, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, sensory hypersensitivity, increased intracranial pressure, impaired coordination, peripheral neuropathy, polyneuropathy, vision disorders, color vision defects, diplopia, tinnitus, hearing loss, transient hearing loss, hearing damage, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, decreased appetite, gastrointestinal discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, pseudomembranous colitis, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, drug rash with eosinophilia and systemic symptoms, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and spasms, joint swelling, muscle weakness, partial or complete tendon rupture, renal impairment, increased BUN, elevated serum creatinine, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undetermined pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, injection site rash, injection site itching, injection site urticaria, aortic aneurysm, aortic dissection, valvular regurgitation, valvular insufficiency, shock, myalgia, weakness, elevated creatine kinase, increased serum and urine myoglobin, rhabdomyolysis, cough, abnormal chest X-ray, eosinophilia, interstitial pneumonia, visual impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture exposure. Additionally, it is best to store it at room temperature between 1 to 30 degrees Celsius. Avoiding excessively hot or cold places will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.